BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ for CVS HEALTH
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to COVID-19 testing and health care coverage; COVID-19 emergency response, in general; drug pricing, in general; home and community-based services, in general; H.R.5376 - Build Back Better Act - provisions related to health care coverage, drug pricing, and taxation; issues related to the 340B program and clinical trials; H.R.7213 - Equitable Community Access to Pharmacist Services Act; S.4293 - Pharmacy Benefit Manager Transparency Act of 2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS DASCHLE | Former United States Senator |
| TIFFANI VIVIENNE WILLIAMS | — |
Medicare/Medicaid MMM
Policy and reimbursement changes to the MA program
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANI VIVIENNE WILLIAMS | — |
Taxation/Internal Revenue Code TAX
S.1260 - United States Innovation and Competition Act of 2021, provisions relating to research and development tax deductibility and the sale of online goods; H.R.4521 - United States Innovation and Competition Act of 2021, provisions relating to provisions relating to research and development tax deductibility and the sale of online goods.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIFFANI VIVIENNE WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.